
Escolha o seu rótulo
visível diretamente no frascoRelatório laboratorial
PDF- Testado
- Thymosin Alpha-1 5mg
- Laboratório
- Analiza Białek
- Data
- November 2026
- Resultado
- 99% purity (5.33 mg measured)
- Endotoxinas
- 4.56 EU/vial
- N.º da encomenda
- Palavra-passe
Testado de forma independente, verificável com a palavra-passe diretamente no laboratório.
Thymosin Alpha-1
Immune System
- Testado em laboratório · 99% de pureza
- Enviado da Alemanha
Encomenda
- DHL com seguimento
- Embalagem discreta
Num relance
Thymosin Alpha-1 em números
Os valores-chave da nossa enciclopédia.
Entrada completa da enciclopédia- Class
- Immune-modulating peptidethymus-derived
- Frequency
- ~2x per weekin phases
- Form
- Lyophilised powderreconstituted with BAC water
- Sizes
- 5 to 10 mg2 sizes in the shop
What studies show
The source in the lexiconRandomized controlled study of thymosin alpha-1 in severe sepsis (ETASS) (opens in a new tab)
Wu et al., Critical Care, 2013
Avaliações
O que dizem os clientes
Apenas encomendas reais que incluíam Thymosin Alpha-1.
Todas as avaliaçõesConhecimento
Tudo sobre Thymosin Alpha-1
Informação detalhada disponível em breve.
Dosagem
A carregar informação de dosagem …
Convém ter
O que precisa para isto
A água bacteriostática é adicionada automaticamente ao carrinho. Seringas e toalhetes com um clique.
Seringas de insulina
10 un. · 5.50 €
Toalhetes com álcool
50 un. · 10 €
Quanta água?
Unidades na seringa para o tamanho do seu frasco.
Abrir calculadora →Is Thymosin Alpha-1 approved?
Yes, but not everywhere. As thymalfasin it is approved in over 35 countries according to a 2009 review, mainly for hepatitis B and C and to strengthen the immune system. There is no approval in the US, ChEMBL lists the compound at phase 3.
How does Thymosin Alpha-1 work?
In cell and mouse experiments it made dendritic cells more active, the cells that show pathogens to the immune system. This ran via the receptor TLR9. At the same time it promoted regulatory T cells, which slow down excessive reactions. ChEMBL lists no confirmed mechanism in humans.
What do the sepsis trials show?
In ETASS with 361 people 26 percent died within 28 days with Thymosin Alpha-1 and 35 percent without, a difference that just missed certainty. The larger TESTS trial with 1,106 people and placebo found 23.4 versus 24.1 percent, so no difference. A possible benefit from age 60 counts only as a hint there.
Are there data on cancer?
In a trial with 488 people with advanced melanoma Thymosin Alpha-1 was added to chemo. The highest study dose was 6.4 mg. More tumours responded and median survival was 9.4 versus 6.6 months, but not statistically certain. There were no extra side effects.
Does it help in severe pancreatitis?
Not with certainty in the TRACE trial with 508 people. Infected dead tissue occurred in 15.7 percent with Thymosin Alpha-1 and 18.1 percent on placebo. The main goal was therefore not reached.
Which side effects are known?
In TESTS 66.4 percent on Thymosin Alpha-1 and 67.6 percent on placebo had an adverse event, serious events were 26.8 versus 29.3 percent. ETASS recorded no serious side effects caused by the drug. With autoimmune disease the regular entry advises restraint.
Relacionados
Produtos relacionados
Thymalin
Péptidos · Sistema imunitário Sistema imunitário
2 tamanhos
= a partir de 16 €/frasco
KPV
Péptidos · Sistema imunitário Sistema imunitário
4 tamanhos
Testado em laboratório
= a partir de 11.6 €/frasco
VIP
Péptidos · Sistema imunitário Sistema imunitário
2 tamanhos
= a partir de 23.2 €/frasco
VIP Nasal
Péptidos · Sistema imunitário Sistema imunitário
1 tamanho
Thymosin Alpha-1